PB1906: IS THERE A PLACE FOR IMATINIB IN THE FIRST-LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA CHRONIC PHASE: REAL LIFE DATA FROM UNIVERSITY CENTER AFTER LONG PERIOD OF FOLLOW-UP

por Lekovic, D., Jovanovic, J., Djordjevic, V., Milosevic, V., Bodrozic, J., Bogdanovic, A.
Publicado 2022